SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-013355
Filing Date
2019-04-26
Accepted
2019-04-26 16:07:27
Documents
5
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A prtk-defa14a_20190612.htm DEFA14A 40564
2 GRAPHIC gft0rt3ua41j000003.jpg GRAPHIC 20563
3 GRAPHIC gft0rt3ua41j000004.jpg GRAPHIC 9145
4 GRAPHIC gft0rt3ua41j000002.jpg GRAPHIC 85569
5 GRAPHIC gft0rt3ua41j000001.jpg GRAPHIC 52550
  Complete submission text file 0001564590-19-013355.txt   273469
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36066 | Film No.: 19771810
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1